Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: July 2017

7/31/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (June and 1st Half of 2017)

Between January and June 2017, Russian manufacturers dispatch 159.8 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is 5.5% higher than that of the same period of 2016. In physical terms, the volume is 2.03 bln units, which is only 1.7% higher than that of the same period of 2016.

7/20/2017 Database Update: API Import to Russia (June and 1st Half of 2017)

Between January and June 2017, Russia imported 5,600 tons of active pharmaceutical ingredients (API), worth 35.7 bln RUB (free circulation prices). In monetary terms, it is 30% higher than that of the same period of 2016. In physical terms, the dynamics is 7%.

7/20/2017 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (June and 1st Half of 2017)

Between January and June 2017, Russia imported 10.9 bln RUB worth of veterinary drugs (free circulation prices), 0.8 bln RUB worth of veterinary APIs, and 13.2 bln RUB worth of feed supplements and premixes. The import of veterinary APIs has the best dynamics in monetary terms (6.7%). The import of feed supplements shows the worst dynamics, with only 2.9%. The import of veterinary drugs has risen by 5.2%.

7/17/2017 Database Update: Pharmaceutical Drug Import to Russia (June 2017)

Between January and June 2017, Russia imported 238.5 bln RUB worth of ready-made drugs (free circulation prices), which is 8.1% higher in monetary terms. Due to the poor June performance, the long-term dynamics are -1%. The in-bulk import has been falling down for four months, with 42.7 bln RUB, which is 25.5% lower than that of 2016.

7/11/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (May 2017)

Between January and May 2017, Russian manufacturers produced and dispatched 135.5 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 11.1% higher than that of the same period of 2016. This is twice as low as the dynamics of 2015-2016. In physical terms, the dispatch volume is 1.73 bln units, which is 3.6% higher than that of the same period of 2016.